Efficacy of transurethral blue laser prostatomy in the treatment of small volume benign prostatic hyperplasia
10.3969/j.issn.1009-8291.2024.11.010
- VernacularTitle:经尿道蓝激光前列腺切开术治疗小体积良性前列腺增生的临床疗效
- Author:
Miao YAO
1
;
Ning TAO
2
;
Xiaodong LI
1
;
Maimaitiming ABULAITI
1
;
Apizi AIRETI
1
;
Niyazi SIDIKEJIANG
1
;
Hengqing AN
1
Author Information
1. Department of Urology, The First Affiliated Hospital, Urumqi 830054, China
2. Public Health Institute, Xinjiang Medical University, Urumqi 830054, China
- Publication Type:Journal Article
- Keywords:
transurethral blue laser prostatomy;
450 nm blue laser;
small volume;
benign prostatic hyperplasia
- From:
Journal of Modern Urology
2024;29(11):984-987
- CountryChina
- Language:Chinese
-
Abstract:
[Objective] To explore the clinical efficacy and feasibility of blue laser transurethral incision of prostate (BLTUIP) in the treatment of small volume (≤30 mL) benign prostatic hyperplasia (BPH). [Methods] The clinical data of 34 BPH patients treated with BLTUIP in the First Affiliated Hospital of Xinjiang Medical University during Mar.and Oct.2023 were retrospectively analyzed.The operation time, 450 nm blue laser light emission time, 980 nm red laser light emission time, postoperative bladder irrigation time, international prostate symptom score (IPSS), quality of life score (QoL), maximum flow rate (Qmax), post-void residual (PVR), international index of erectile function-5 (IIEF-5), ejaculation and incidence of postoperative complications were analyzed. [Results] All operations were successful, without conversion to open or transurethral resection of the prostate (TURP). The operation time was 12.7 (10.8, 14.3) min, the 450 nm blue laser light emission time was 11.7 (9.6, 13.3) min, the 980 nm red laser light emission time was 1.0 (1.0, 2.0) min, the postoperative bladder irrigation time was 5.0 (2.8, 8.0) h, the total hospital stay was 6.0 (4.0, 7.0) d, the postoperative hospital stay was 2.0 (2.0, 3.0) d, and the postoperative catheter retention time was 2.0 (0, 2.0) d. After 3 or 6 months of follow-up, the IPSS, QoL and PVR were significantly lower than those before operation, while the Qmax was significantly higher, with significant differences (P<0.001); but there was no significant difference in the IIEF-5 score (P>0.05). During the 3-month follow-up, 4 patients (11.8%) had fever; during the 3-6 month follow-up, 1 patient (2.9%) had external urethral stricture; of the 8 patients with sexual life before operation, 1 (12.5%) had retrograde ejaculation after operation.No hematuria occurred. [Conclusion] BLTUIP is a new, safe and efficient surgical treatment for BPH with a volume ≤30 mL, which can shorten the operation time, reduce postoperative complications, and improve the quality of life.
